Cefadroxil Suspension Rx
Generic Name and Formulations:
Cefadroxil 250mg/5mL, 500mg/5mL; orange-pineapple flavor.
Various generic manufacturers
Indications for Cefadroxil Suspension:
Susceptible urinary tract, skin and skin structure infections, pharyngitis/tonsillitis, impetigo.
Uncomplicated UTI: 1–2g once daily or in 2 divided doses. Complicated UTI: 2g/day in 2 divided doses. Skin and skin structure infections: 1g once daily or in 2 divided doses. Pharyngitis/tonsillitis: 1g once daily or in 2 divided doses for 10 days. Renal dysfunction (CrCl <50mL/min): 1g loading dose, then 500mg at increased dosing intervals (see literature). Continue for 3 days after symptoms improve.
UTI, skin and skin structure infections: 30mg/kg/day in 2 divided doses every 12 hours. Pharyngitis/tonsillitis, impetigo: 30mg/kg once daily or in 2 divided doses for 10 days. Renal dysfunction: reduce dose (see literature). Continue for 3 days after symptoms improve.
Penicillin or other allergy. Discontinue if colitis occurs and treat. Impaired renal function (CrCl <50mL/min). GI disease (esp. colitis). Pregnancy (Cat.B). Nursing mothers.
Potentiated by probenecid. May cause false (+) Clinitest or Coomb's test.
GI upset, anaphylaxis, rash; blood dyscrasias (rare).
Formerly known under the brand names Duricef, Ultracef.
Clinical Pain Advisor Articles
- FDA Takes Steps to Reconcile Needs of Patients With Chronic Pain, Efforts to Curb Opioid Epidemic
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Stat Consult: Chronic Low Back Pain
- Opioid Misuse May Help Predict Alcohol Dependence Treatment Outcomes
- Neuropathic Symptoms Worsen Quality of Life, Function in Hip, Knee Osteoarthritis
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- Switching From Buprenorphine-Naltrexone to XR-Naltrexone as Effective as XR-Naltrexone
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Human Diagnosis Project Aims to Address Challenges Among Uninsured
- Healthcare Technology Affects Younger Patient Satisfaction
- FDA Announces New Drug Shortages Task Force